• IT Wallet, entra nella seconda fase
    Terminato il periodo di test, tutto è pronto per il passaggio successivo, quello di validazione dei documenti.

    Gli utenti che hanno preso parte alla sperimentazione, dal 15 luglio, accedendo all’appIO – tramite Spid o Carta d’identità elettronica (Cie), o scaricandola da Play store per Android o da Apple store per iPhone, hanno ricevuto un avviso con la comunicazione che si è parte del test e il riferimento all’icona per IT Wallet, dove caricare i 3 documenti ammessi in questa prima fase. La validazione dei documenti, è uno step successivo che arriverà tra settembre e ottobre. L’accesso al portafoglio sarà possibile per tutti gli italiani che hanno raggiunto la maggiore età: potranno inizialmente caricare la versione digitale dei primi tre documenti disponibili, dopodiché la categoria sarà ampliata. L’obiettivo è di rendere tutti i documenti verificabili da IT Wallet dal 2025, compresi passaporto, certificato di nascita e tessera elettorale.

    Fonte: https://t.me/NoDigitalChannel
    IT Wallet, entra nella seconda fase Terminato il periodo di test, tutto è pronto per il passaggio successivo, quello di validazione dei documenti. Gli utenti che hanno preso parte alla sperimentazione, dal 15 luglio, accedendo all’appIO – tramite Spid o Carta d’identità elettronica (Cie), o scaricandola da Play store per Android o da Apple store per iPhone, hanno ricevuto un avviso con la comunicazione che si è parte del test e il riferimento all’icona per IT Wallet, dove caricare i 3 documenti ammessi in questa prima fase. La validazione dei documenti, è uno step successivo che arriverà tra settembre e ottobre. L’accesso al portafoglio sarà possibile per tutti gli italiani che hanno raggiunto la maggiore età: potranno inizialmente caricare la versione digitale dei primi tre documenti disponibili, dopodiché la categoria sarà ampliata. L’obiettivo è di rendere tutti i documenti verificabili da IT Wallet dal 2025, compresi passaporto, certificato di nascita e tessera elettorale. Fonte: https://t.me/NoDigitalChannel
    Angry
    2
    0 Commenti 0 Condivisioni 55 Visualizzazioni
  • The research analysis on the global Cannabis Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Cannabis Market circumstances in the forecast period between 2024 and 2031. The global Cannabis Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements.

    Market Growth

    The Cannabis Market has experienced robust growth over the past decade and is projected to continue expanding. Global Cannabis Market size was valued at USD 36.4 Billion in 2022 poised to grow from USD 42.6 Billion in 2023 to USD 148.4 Billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

    Chance to get a free sample @ https://www.skyquestt.com/sample-request/cannabis-market
    The research analysis on the global Cannabis Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Cannabis Market circumstances in the forecast period between 2024 and 2031. The global Cannabis Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Cannabis Market has experienced robust growth over the past decade and is projected to continue expanding. Global Cannabis Market size was valued at USD 36.4 Billion in 2022 poised to grow from USD 42.6 Billion in 2023 to USD 148.4 Billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/cannabis-market
    WWW.SKYQUESTT.COM
    Cannabis Market Size, Share & Growth Report | 2024-2031
    The Cannabis Market size is poised to grow from USD 42.6 Billion in 2023 to USD 148.4 Billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).
    0 Commenti 0 Condivisioni 48 Visualizzazioni
  • Modular car body moulds offer manufacturers greater flexibility in their production processes. The ability to quickly swap out modules enables manufacturers to switch between different car models or design variations with minimal downtime. This adaptability is particularly valuable in an industry where model lifecycles are becoming shorter and customization is increasingly demanded by consumers.
    https://www.autolampmold.com/product/
    Modular car body moulds offer manufacturers greater flexibility in their production processes. The ability to quickly swap out modules enables manufacturers to switch between different car models or design variations with minimal downtime. This adaptability is particularly valuable in an industry where model lifecycles are becoming shorter and customization is increasingly demanded by consumers. https://www.autolampmold.com/product/
    0 Commenti 0 Condivisioni 56 Visualizzazioni
  • Fill-finish Pharmaceutical Contract Market Global outlook 2024 to 2031 | Skyquest



    Leading market research firm SkyQuest Technology Group recently released a study titled 'Fill-finish Pharmaceutical Contract Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Fill-finish Pharmaceutical Contract report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Fill-finish Pharmaceutical Contract Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.


    The research analysis on the global Fill-finish Pharmaceutical Contract Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Fill-finish Pharmaceutical Contract Market circumstances in the forecast period between 2024 and 2031. The global Fill-finish Pharmaceutical Contract Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements.

    Market Growth

    The Fill-finish Pharmaceutical Contract Market has experienced robust growth over the past decade and is projected to continue expanding. In 2022, the global fill-finish pharmaceutical contract manufacturing market reached a significant value of USD 8.1 billion. Projections indicate that this market is poised for steady growth, with an estimated compound annual growth rate (CAGR) of 6.1% expected from 2024 to 2031. This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

    Chance to get a free sample @ https://www.skyquestt.com/sample-request/fill-finish-pharmaceutical-contract-manufacturing-market

    Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR):

    The Fill-finish Pharmaceutical Contract Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

    By Product Type - Prefilled Syringes, Vials, Cartridges, Others
    By Molecule Type - Large Molecules, Small Molecules
    By End-user - Biopharmaceutical Companies, Pharmaceutical Companies
    By Region - North America, Asia Pacific, Latin America, Europe
    Get your customized report @ https://www.skyquestt.com/speak-with-analyst/fill-finish-pharmaceutical-contract-manufacturing-market

    Following are the players analyzed in the report:

    AbbVie Inc.
    Boehringer Ingelheim
    Pfizer
    Catalent Inc
    Recro Pharma, Inc.
    Baxter’s BioPharma Solutions
    Eurofins Scientific
    Symbiosis Pharmaceutical Service
    MabPlex International Co. Ltd.
    Recipharm AB
    Fresenius Kabi Contract Manufacturing
    Novartis
    Regional Analysis

    1. North America:
    - The United States and Canada dominate the North American Fill-finish Pharmaceutical Contract Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Fill-finish Pharmaceutical Contract consumption.

    2. Europe:
    - Europe is a significant player, with major Fill-finish Pharmaceutical Contract Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector.

    3. Asia-Pacific:
    - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Fill-finish Pharmaceutical Contract manufacturing capabilities contribute to this growth.

    4. Latin America:
    - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications.

    5. Middle East and Africa:
    - The Fill-finish Pharmaceutical Contract Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions.

    Future Outlook

    The Fill-finish Pharmaceutical Contract Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

    Buy your full report: https://www.skyquestt.com/buy-now/fill-finish-pharmaceutical-contract-manufacturing-market
    Fill-finish Pharmaceutical Contract Market Global outlook 2024 to 2031 | Skyquest Leading market research firm SkyQuest Technology Group recently released a study titled 'Fill-finish Pharmaceutical Contract Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Fill-finish Pharmaceutical Contract report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Fill-finish Pharmaceutical Contract Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Fill-finish Pharmaceutical Contract Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Fill-finish Pharmaceutical Contract Market circumstances in the forecast period between 2024 and 2031. The global Fill-finish Pharmaceutical Contract Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Fill-finish Pharmaceutical Contract Market has experienced robust growth over the past decade and is projected to continue expanding. In 2022, the global fill-finish pharmaceutical contract manufacturing market reached a significant value of USD 8.1 billion. Projections indicate that this market is poised for steady growth, with an estimated compound annual growth rate (CAGR) of 6.1% expected from 2024 to 2031. This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/fill-finish-pharmaceutical-contract-manufacturing-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Fill-finish Pharmaceutical Contract Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. By Product Type - Prefilled Syringes, Vials, Cartridges, Others By Molecule Type - Large Molecules, Small Molecules By End-user - Biopharmaceutical Companies, Pharmaceutical Companies By Region - North America, Asia Pacific, Latin America, Europe Get your customized report @ https://www.skyquestt.com/speak-with-analyst/fill-finish-pharmaceutical-contract-manufacturing-market Following are the players analyzed in the report: AbbVie Inc. Boehringer Ingelheim Pfizer Catalent Inc Recro Pharma, Inc. Baxter’s BioPharma Solutions Eurofins Scientific Symbiosis Pharmaceutical Service MabPlex International Co. Ltd. Recipharm AB Fresenius Kabi Contract Manufacturing Novartis Regional Analysis 1. North America: - The United States and Canada dominate the North American Fill-finish Pharmaceutical Contract Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Fill-finish Pharmaceutical Contract consumption. 2. Europe: - Europe is a significant player, with major Fill-finish Pharmaceutical Contract Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Fill-finish Pharmaceutical Contract manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Fill-finish Pharmaceutical Contract Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Fill-finish Pharmaceutical Contract Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/fill-finish-pharmaceutical-contract-manufacturing-market
    WWW.SKYQUESTT.COM
    Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share, Growth Analysis - Industry Forecast 2023-2030
    Fill-finish Pharmaceutical Contract Manufacturing Market report covers growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
    0 Commenti 0 Condivisioni 116 Visualizzazioni
  • Cartilage Repair Market Global Latest Trends and Insights 2024 to 2031



    Leading market research firm SkyQuest Technology Group recently released a study titled ‘Cartilage Repair Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024–2031,’ This study Cartilage Repair report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Cartilage Repair Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

    The research analysis on the global Cartilage Repair Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Cartilage Repair Market circumstances in the forecast period between 2024 and 2031. The global Cartilage Repair Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements.

    Market Growth

    The Cartilage Repair Market has experienced robust growth over the past decade and is projected to continue expanding. Cartilage Repair Market size was valued at USD 927.63 million in 2022 and is poised to grow from USD 1040.29 million in 2023 to USD 1570.16 million by 2031, growing at a CAGR of 12.13% in the forecast period (2024–2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

    Chance to get a free sample @ https://www.skyquestt.com/sample-request/cartilage-repair-market

    Detailed Segmentation and Classification of the report (Market Size and Forecast — 2031, Y-o-Y growth rate, and CAGR):

    The Cartilage Repair Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

    Treatment modality type
    Cell-Based (Chondrocyte Transplantation, Growth Factor Technology), Non-Cell-Based (Tissue Scaffolds, Cell-Free Composites)
    Application
    Hyaline, Fibrocartilage
    Treatment type
    Palliative (Viscosupplementation, Debridement & Lavage), Intrinsic Repair Stimulus
    Site
    Knee Cartilage Repair (Arthroscopic Chondroplasty, Autologous Chondrocyte, Osteochondral Grafts Transplantation, Cell-based Cartilage Resurfacing, Microfracture, Other), Other
    Regional Analysis:

    On the basis of region, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The Cartilage Repair Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

    Get your customized report @ https://www.skyquestt.com/speak-with-analyst/cartilage-repair-market

    Following are the players analyzed in the report:

    DePuy Synthes (a subsidiary of Johnson & Johnson)
    Zimmer Biomet Holdings Inc.
    Smith & Nephew plc
    Vericel Corporation
    Osiris Therapeutics Inc. (acquired by Smith & Nephew in 2019)
    Histogenics Corporation
    Anika Therapeutics Inc.
    Arthrex Inc.
    B. Braun Melsungen AG
    Stryker Corporation
    CONMED Corporation
    Orthocell Limited
    RTI Surgical Holdings Inc.
    MEDIPOST Co. Ltd.
    CellGenix GmbH
    Tissue Regenix Group plc
    CollPlant Biotechnologies Ltd.
    ISTO Technologies Inc.
    MTF Biologics
    CartiHeal Ltd
    Regional Analysis

    1. North America:
    - The United States and Canada dominate the North American Cartilage Repair Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Cartilage Repair consumption.

    2. Europe:
    - Europe is a significant player, with major Cartilage Repair Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector.

    3. Asia-Pacific:
    - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Cartilage Repair manufacturing capabilities contribute to this growth.

    4. Latin America:
    - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications.

    5. Middle East and Africa:
    - The Cartilage Repair Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions.

    Future Outlook

    The Cartilage Repair Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

    Buy your full report: https://www.skyquestt.com/buy-now/cartilage-repair-market
    Cartilage Repair Market Global Latest Trends and Insights 2024 to 2031 Leading market research firm SkyQuest Technology Group recently released a study titled ‘Cartilage Repair Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024–2031,’ This study Cartilage Repair report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Cartilage Repair Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Cartilage Repair Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Cartilage Repair Market circumstances in the forecast period between 2024 and 2031. The global Cartilage Repair Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Cartilage Repair Market has experienced robust growth over the past decade and is projected to continue expanding. Cartilage Repair Market size was valued at USD 927.63 million in 2022 and is poised to grow from USD 1040.29 million in 2023 to USD 1570.16 million by 2031, growing at a CAGR of 12.13% in the forecast period (2024–2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/cartilage-repair-market Detailed Segmentation and Classification of the report (Market Size and Forecast — 2031, Y-o-Y growth rate, and CAGR): The Cartilage Repair Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. Treatment modality type Cell-Based (Chondrocyte Transplantation, Growth Factor Technology), Non-Cell-Based (Tissue Scaffolds, Cell-Free Composites) Application Hyaline, Fibrocartilage Treatment type Palliative (Viscosupplementation, Debridement & Lavage), Intrinsic Repair Stimulus Site Knee Cartilage Repair (Arthroscopic Chondroplasty, Autologous Chondrocyte, Osteochondral Grafts Transplantation, Cell-based Cartilage Resurfacing, Microfracture, Other), Other Regional Analysis: On the basis of region, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The Cartilage Repair Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications. Get your customized report @ https://www.skyquestt.com/speak-with-analyst/cartilage-repair-market Following are the players analyzed in the report: DePuy Synthes (a subsidiary of Johnson & Johnson) Zimmer Biomet Holdings Inc. Smith & Nephew plc Vericel Corporation Osiris Therapeutics Inc. (acquired by Smith & Nephew in 2019) Histogenics Corporation Anika Therapeutics Inc. Arthrex Inc. B. Braun Melsungen AG Stryker Corporation CONMED Corporation Orthocell Limited RTI Surgical Holdings Inc. MEDIPOST Co. Ltd. CellGenix GmbH Tissue Regenix Group plc CollPlant Biotechnologies Ltd. ISTO Technologies Inc. MTF Biologics CartiHeal Ltd Regional Analysis 1. North America: - The United States and Canada dominate the North American Cartilage Repair Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Cartilage Repair consumption. 2. Europe: - Europe is a significant player, with major Cartilage Repair Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Cartilage Repair manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Cartilage Repair Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Cartilage Repair Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/cartilage-repair-market
    WWW.SKYQUESTT.COM
    Cartilage Repair Market Growth, Size & Share Analysis | 2031
    Cartilage Repair Market By Treatment modality type(Cell-Based (Chondrocyte Transplantation, Growth Factor Technology)), By Application(Hyaline, Fibrocartilage), By Treatment type(Palliative (Viscosupplementation, Debridement & Lavage)), By Site(Knee Cartilage Repair (Arthroscopic Chondroplasty, Autologous Chondrocyte) and By Region.
    0 Commenti 0 Condivisioni 149 Visualizzazioni
  • ALEXANDER DUGIN: LA TERZA GUERRA MONDIALE È UFFICIALMENTE INIZIATA

    Israele, dopo aver affrontato Gaza, ovvero dopo aver commesso un genocidio di massa di civili davanti agli occhi del mondo intero, ha iniziato una guerra a tutto campo con il Libano. Proprio come a Gaza gli israeliani hanno preferito affermare di combattere Hamas piuttosto che i palestinesi nel loro insieme (come in realtà è stato), così ora Netanyahu sta parlando di contrastare Hezbollah lanciando attacchi missilistici di massa e bombardamenti a tappeto di civili nel paese sovrano del Libano. Questa è guerra nel senso più pieno del termine. E l'Occidente sostiene pienamente l'aggressione di Israele.

    Dopo quello ucraino, si può considerare aperto il secondo fronte tra egemonia unipolare e rafforzamento della multipolarità.

    L'Occidente è in guerra con la Russia per mano dei nazisti ucraini e con gli sciiti per mano dei nazisti israeliani. Ed è pronto a iniziare una guerra con la Cina per mano dei nazisti taiwanesi. La NATO lancerà ulteriori eserciti europei contro la Russia, eserciti sunniti contro l'Iran e il Libano e sosterrà Taiwan con l'alleanza tra India, Giappone e Corea del Sud.

    Se tutto questo non è la Terza Guerra Mondiale, allora cos'è?

    @Dugin_Aleksandr
    ALEXANDER DUGIN: LA TERZA GUERRA MONDIALE È UFFICIALMENTE INIZIATA Israele, dopo aver affrontato Gaza, ovvero dopo aver commesso un genocidio di massa di civili davanti agli occhi del mondo intero, ha iniziato una guerra a tutto campo con il Libano. Proprio come a Gaza gli israeliani hanno preferito affermare di combattere Hamas piuttosto che i palestinesi nel loro insieme (come in realtà è stato), così ora Netanyahu sta parlando di contrastare Hezbollah lanciando attacchi missilistici di massa e bombardamenti a tappeto di civili nel paese sovrano del Libano. Questa è guerra nel senso più pieno del termine. E l'Occidente sostiene pienamente l'aggressione di Israele. Dopo quello ucraino, si può considerare aperto il secondo fronte tra egemonia unipolare e rafforzamento della multipolarità. L'Occidente è in guerra con la Russia per mano dei nazisti ucraini e con gli sciiti per mano dei nazisti israeliani. Ed è pronto a iniziare una guerra con la Cina per mano dei nazisti taiwanesi. La NATO lancerà ulteriori eserciti europei contro la Russia, eserciti sunniti contro l'Iran e il Libano e sosterrà Taiwan con l'alleanza tra India, Giappone e Corea del Sud. Se tutto questo non è la Terza Guerra Mondiale, allora cos'è? @Dugin_Aleksandr
    Like
    1
    0 Commenti 0 Condivisioni 252 Visualizzazioni
  • Nel frattempo in Spagna i gestori di hotel, bungalow, campeggi e società di autonoleggio dovranno fornire obbligatoriamente al Governo più di 40 dettagli dei propri clienti, compresi numero di conto bancario, numero di telefono, documento e anche tipo di auto a noleggio.

    I cordoni del controllo, come da agenda, si stanno stringendo.

    La soluzione? Boicottare qualsiasi paese che applichi politiche restrittive di controllo sociale.

    Stiamo andando sempre più incontro all’ossimoro secondo il quale più libertà = più controllo = più sicurezza.
    E la gente si berrà anche questa!

    Fonte
    Leonardo SANTI Telegram
    Nel frattempo in Spagna i gestori di hotel, bungalow, campeggi e società di autonoleggio dovranno fornire obbligatoriamente al Governo più di 40 dettagli dei propri clienti, compresi numero di conto bancario, numero di telefono, documento e anche tipo di auto a noleggio. I cordoni del controllo, come da agenda, si stanno stringendo. La soluzione? Boicottare qualsiasi paese che applichi politiche restrittive di controllo sociale. Stiamo andando sempre più incontro all’ossimoro secondo il quale più libertà = più controllo = più sicurezza. E la gente si berrà anche questa! Fonte 🔗Leonardo SANTI Telegram
    Angry
    1
    0 Commenti 0 Condivisioni 273 Visualizzazioni
  • Io Non Mi Vaccino 👎🏻, [24 Set 2024 alle 10:57]
    Bill Gates in tribunale nei Paesi Bassi: le vittime del vaccino chiedono giustizia per il danno subito

    Mercoledì si è tenuta un'udienza provvisoria presso il tribunale olandese di Leeuwarden, che Bill Gates ha avviato in risposta alla causa principale intentata dagli avvocati Arno van Kessel e Peter Stassen per conto delle persone colpite dalla vaccinazione.

    ⏺ In questo caso, Gates è uno dei 17 imputati nel progetto “COVID-19: The Great Reset”.
    Sette vittime del vaccino chiedono giustizia per il danno causato loro dalla vaccinazione. Uno di loro è morto.

    Gates sta cercando di evitare il procedimento e quindi ha chiesto una dichiarazione orale in tribunale.

    ⏺ È sorprendente che egli non fosse presente all'udienza perché non ritiene che il tribunale di Leeuwarden sia competente.
    È rappresentato da un avvocato dello studio legale Pels Rijcken.

    Secondo gli avvocati delle vittime, il tribunale olandese è effettivamente competente a condannare Gates.

    Essi si basano sull'articolo 6 del codice di procedura civile, che recita: “Il giudice olandese è inoltre competente per le azioni illecite se l'evento dannoso si è verificato o potrebbe verificarsi nei Paesi Bassi.

    ⏺ Dopo l'audizione orale, in serata si è tenuta una conferenza stampa nella quale la stampa ha potuto rivolgere domande al sig. Van Kessel e al sig. Stassen.

    Erica Krikke di Zebra Inspiratie ha parlato in tribunale con l'ex GP Berber Pieksma, anch'egli presente all'udienza.

    ⏺ "Pensavo che la cosa peggiore dell'intero caso fosse che nella loro risposta hanno osato dubitare che i querelanti fossero vaccinati" ha detto Pieksma.
    "È stato davvero subdolo."

    Una delle ricorrenti, una donna di 50 anni, non era mai stata veramente malata prima della vaccinazione anti-coronavirus.

    ⏺ Ora è molto malata. Voleva cogliere l'occasione per parlare di ciò che le ha fatto.
    "È stata una storia molto emozionante", ha detto Krikke.

    I suoi avvocati hanno detto che la sua storia era importante per mostrare la connessione.

    ⏺ Ha parlato anche a nome del querelante deceduto, che è stato sottoposto alla stessa procedura di iniezione ma è morto sei mesi prima.

    “Dei sette, ne restano solo sei. Tre erano troppo malati per venire e tre erano presenti”.

    ⏺ Durante l'udienza, l'avvocato di Gates ha avanzato ogni sorta di argomentazioni sul motivo per cui credeva che il giudice non avesse giurisdizione.

    Alla fine l'avvocato ha detto: “Forse dovremmo andare ad Amsterdam o all'Aja per sapere se un tribunale olandese è competente”.

    ⏺ Vogliono davvero che vada ad Arnhem o all’Aia, questi sono tutti tribunali dove non esiste più giurisprudenza”, ha detto Pieksma, aggiungendo che “facevano tutti parte della cricca”.

    "Era strano come sostenesse che il caso dovesse effettivamente andare in un altro tribunale", ha sottolineato l'ex medico di famiglia.

    Il giudice si pronuncerà tra qualche settimana.
    Fonte

    Iscriviti https://t.me/noalvaccino https://t.me/noalvaccino/57729
    Io Non Mi Vaccino 💉👎🏻, [24 Set 2024 alle 10:57] 🤡 Bill Gates in tribunale nei Paesi Bassi: le vittime del vaccino chiedono giustizia per il danno subito 💉 Mercoledì si è tenuta un'udienza provvisoria presso il tribunale olandese di Leeuwarden, che Bill Gates ha avviato in risposta alla causa principale intentata dagli avvocati Arno van Kessel e Peter Stassen per conto delle persone colpite dalla vaccinazione. ⏺ In questo caso, Gates è uno dei 17 imputati nel progetto “COVID-19: The Great Reset”. Sette vittime del vaccino chiedono giustizia per il danno causato loro dalla vaccinazione. Uno di loro è morto. Gates sta cercando di evitare il procedimento e quindi ha chiesto una dichiarazione orale in tribunale. ⏺ È sorprendente che egli non fosse presente all'udienza perché non ritiene che il tribunale di Leeuwarden sia competente. È rappresentato da un avvocato dello studio legale Pels Rijcken. ⚖️ Secondo gli avvocati delle vittime, il tribunale olandese è effettivamente competente a condannare Gates. Essi si basano sull'articolo 6 del codice di procedura civile, che recita: “Il giudice olandese è inoltre competente per le azioni illecite se l'evento dannoso si è verificato o potrebbe verificarsi nei Paesi Bassi. ⏺ Dopo l'audizione orale, in serata si è tenuta una conferenza stampa nella quale la stampa ha potuto rivolgere domande al sig. Van Kessel e al sig. Stassen. Erica Krikke di Zebra Inspiratie ha parlato in tribunale con l'ex GP Berber Pieksma, anch'egli presente all'udienza. ⏺ "Pensavo che la cosa peggiore dell'intero caso fosse che nella loro risposta hanno osato dubitare che i querelanti fossero vaccinati" ha detto Pieksma. "È stato davvero subdolo." Una delle ricorrenti, una donna di 50 anni, non era mai stata veramente malata prima della vaccinazione anti-coronavirus. ⏺ Ora è molto malata. Voleva cogliere l'occasione per parlare di ciò che le ha fatto. "È stata una storia molto emozionante", ha detto Krikke. I suoi avvocati hanno detto che la sua storia era importante per mostrare la connessione. ⏺ Ha parlato anche a nome del querelante deceduto, che è stato sottoposto alla stessa procedura di iniezione ma è morto sei mesi prima. “Dei sette, ne restano solo sei. Tre erano troppo malati per venire e tre erano presenti”. ⏺ Durante l'udienza, l'avvocato di Gates ha avanzato ogni sorta di argomentazioni sul motivo per cui credeva che il giudice non avesse giurisdizione. Alla fine l'avvocato ha detto: “Forse dovremmo andare ad Amsterdam o all'Aja per sapere se un tribunale olandese è competente”. ⏺ Vogliono davvero che vada ad Arnhem o all’Aia, questi sono tutti tribunali dove non esiste più giurisprudenza”, ha detto Pieksma, aggiungendo che “facevano tutti parte della cricca”. "Era strano come sostenesse che il caso dovesse effettivamente andare in un altro tribunale", ha sottolineato l'ex medico di famiglia. ⚖️ Il giudice si pronuncerà tra qualche settimana. Fonte ✉️ Iscriviti ➡️ https://t.me/noalvaccino https://t.me/noalvaccino/57729
    Angry
    1
    0 Commenti 0 Condivisioni 392 Visualizzazioni
  • TORNATE AL CAFFÈ
    CON LA MOKA
    Sono una capsula
    di allumino e dentro
    ho 4 grammi di caffè.
    4 grammi di caffè
    a 0,40 euro, fanno
    100 Euro al kg.
    Per una tonnellata di alluminio vengono prodotte quattro tonnellate di residui sotto forma di arsenico, titanio, cromo, piombo, vanadio, mercurio.
    Sostanze che vanno ad inquinare l’ambiente.
    Grazie ad una produzione di una tonnellata di caffè a settimana sono la regina del mercato.
    Il caffè che uso è quello che costa di meno.
    Quando le polveri tradizionali vengono torrefatte a 200/220°
    in 20 minuti per me la torrefazione è a 1000°C per 90 secondi.
    Anche questo per risparmiare.
    Però il mio caffè è schiumoso e buono.
    Semplicemente perché non contengo solo caffè ma anche un po' di grassi animali, e additivi top secret.
    In più le macchine che vengono utilizzate hanno enormi costi economici ed ambientali per la loro produzione e per il loro smaltimento.
    E non dimenticare l’energia elettrica che usano.
    Ma attento, ti dono non solo caffeina ma anche furano che ingoi con piacere.
    Il furano è una sostanza organica (prodotto intermedio utilizzato nell'industria chimica come solvente per le Resine durante la produzione di lacche
    e come agglomerante nella fonderia).
    È volatile, lipofilo
    e CANCEROGENO
    per il fegato.

    (testo tratto da “Mouvement pour la Terre”, tradotto e rielaborato spero correttamente)

    Fonte: https://x.com/itsmeback_/status/1838123927228281164?t=K-qAQL9fMIvq3ECmifb6Bw&s=19
    TORNATE AL CAFFÈ CON LA MOKA Sono una capsula di allumino e dentro ho 4 grammi di caffè. 4 grammi di caffè a 0,40 euro, fanno 100 Euro al kg. Per una tonnellata di alluminio vengono prodotte quattro tonnellate di residui sotto forma di arsenico, titanio, cromo, piombo, vanadio, mercurio. Sostanze che vanno ad inquinare l’ambiente. Grazie ad una produzione di una tonnellata di caffè a settimana sono la regina del mercato. Il caffè che uso è quello che costa di meno. Quando le polveri tradizionali vengono torrefatte a 200/220° in 20 minuti per me la torrefazione è a 1000°C per 90 secondi. Anche questo per risparmiare. Però il mio caffè è schiumoso e buono. Semplicemente perché non contengo solo caffè ma anche un po' di grassi animali, e additivi top secret. In più le macchine che vengono utilizzate hanno enormi costi economici ed ambientali per la loro produzione e per il loro smaltimento. E non dimenticare l’energia elettrica che usano. Ma attento, ti dono non solo caffeina ma anche furano che ingoi con piacere. Il furano è una sostanza organica (prodotto intermedio utilizzato nell'industria chimica come solvente per le Resine durante la produzione di lacche e come agglomerante nella fonderia). È volatile, lipofilo e CANCEROGENO per il fegato. (testo tratto da “Mouvement pour la Terre”, tradotto e rielaborato spero correttamente) Fonte: https://x.com/itsmeback_/status/1838123927228281164?t=K-qAQL9fMIvq3ECmifb6Bw&s=19
    Angry
    2
    0 Commenti 0 Condivisioni 150 Visualizzazioni
  • Oncology Market Rising Trends, Demand and Future Scope 2024 to 2031

    Leading market research firm SkyQuest Technology Group recently released a study titled 'Oncology Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Oncology report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Oncology Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

    The research analysis on the global Oncology Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Oncology Market circumstances in the forecast period between 2024 and 2031. The global Oncology Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements.

    Market Growth

    The Oncology Market has experienced robust growth over the past decade and is projected to continue expanding. Oncology Market size was valued at USD 286.04 billion in 2022 and is poised to grow from USD 309.3 billion in 2023 to USD 581.25 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

    Chance to get a free sample @ https://www.skyquestt.com/sample-request/oncology-market

    Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR):

    The Oncology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

    Cancer Diagnostics & Treatment
    Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy}
    Cancer Type
    Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer
    End-Use
    Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics
    Get your customized report @ https://www.skyquestt.com/speak-with-analyst/oncology-market

    Following are the players analyzed in the report:

    Roche Holding AG
    Novartis International AG
    Bristol-Myers Squibb Company
    Pfizer Inc.
    Merck & Co., Inc.
    AstraZeneca PLC
    Johnson & Johnson
    Sanofi S.A.
    Takeda Pharmaceutical Company Limited
    Amgen Inc.
    AbbVie Inc.
    Eli Lilly and Company
    Gilead Sciences, Inc.
    Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
    Bayer AG
    Biogen Inc.
    Daiichi Sankyo Company, Limited
    Astellas Pharma Inc.
    Eisai Co., Ltd.
    Teva Pharmaceutical Industries Ltd.
    Regional Analysis

    1. North America:
    - The United States and Canada dominate the North American Oncology Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Oncology consumption.

    2. Europe:
    - Europe is a significant player, with major Oncology Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector.

    3. Asia-Pacific:
    - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Oncology manufacturing capabilities contribute to this growth.

    4. Latin America:
    - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications.

    5. Middle East and Africa:
    - The Oncology Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions.

    Future Outlook

    The Oncology Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

    Buy your full report: https://www.skyquestt.com/buy-now/oncology-market
    Oncology Market Rising Trends, Demand and Future Scope 2024 to 2031 Leading market research firm SkyQuest Technology Group recently released a study titled 'Oncology Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Oncology report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Oncology Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Oncology Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Oncology Market circumstances in the forecast period between 2024 and 2031. The global Oncology Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Oncology Market has experienced robust growth over the past decade and is projected to continue expanding. Oncology Market size was valued at USD 286.04 billion in 2022 and is poised to grow from USD 309.3 billion in 2023 to USD 581.25 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/oncology-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Oncology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. Cancer Diagnostics & Treatment Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy} Cancer Type Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer End-Use Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics Get your customized report @ https://www.skyquestt.com/speak-with-analyst/oncology-market Following are the players analyzed in the report: Roche Holding AG Novartis International AG Bristol-Myers Squibb Company Pfizer Inc. Merck & Co., Inc. AstraZeneca PLC Johnson & Johnson Sanofi S.A. Takeda Pharmaceutical Company Limited Amgen Inc. AbbVie Inc. Eli Lilly and Company Gilead Sciences, Inc. Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company) Bayer AG Biogen Inc. Daiichi Sankyo Company, Limited Astellas Pharma Inc. Eisai Co., Ltd. Teva Pharmaceutical Industries Ltd. Regional Analysis 1. North America: - The United States and Canada dominate the North American Oncology Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Oncology consumption. 2. Europe: - Europe is a significant player, with major Oncology Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Oncology manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Oncology Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Oncology Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/oncology-market
    WWW.SKYQUESTT.COM
    Oncology Market Size, Growth & Trends Report | 2031
    Oncology Market By Cancer Diagnostics & Treatment(Cancer Diagnostics {Tumor Biomarker Test, Imaging), By Cancer Type(Lung Cancer, Prostate Cancer), By End-Use(Hospitals, Diagnostic Laboratories) and By Region.
    0 Commenti 0 Condivisioni 578 Visualizzazioni
Altri risultati